Skip to main content
Fig. 3 | BMC Cardiovascular Disorders

Fig. 3

From: Dysregulation of serum miR-361-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients

Fig. 3

Association of miR-361-5p expression with short-term prognosis of ACS patients. a Expression of miR-361-5p in ACS patients with and without MACE. b The results of Kaplan–Meier curves showed that patients with high miR-361-5p levels had a higher probability of developing MACE (Log-Rank P = 0.011). (***P < 0.001 vs. non-MACE ACS patients)

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us